BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report)’s share price rose 0.2% during mid-day trading on Monday . The company traded as high as $0.10 and last traded at $0.12. Approximately 11,886 shares changed hands during mid-day trading, a decline of 90% from the average daily volume of 113,230 shares. The stock had previously closed at $0.12.
BriaCell Therapeutics Stock Performance
The firm’s 50-day moving average price is $0.26 and its 200 day moving average price is $0.27.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
Further Reading
- Five stocks we like better than BriaCell Therapeutics
- How to Capture the Benefits of Dividend Increases
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Use the MarketBeat Dividend Calculator
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Invest in Biotech Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}